The Conversation (0)
ETF Trends reported that LifeSci Index Partners LLC, an investment advisor and index provider, has launched two new biotech ETFs.
ETF Trends reported that LifeSci Index Partners LLC, an investment advisor and index provider, has launched two new biotech ETFs. They are the BioShares Biotechnology Clinical Trials Fund (NASDAQ:BBC) and the BioShares Biotechnology Products Fund (NASDAQ:BBP).
As quoted in the market news:
BBC wil track the BioShares Biotechnology Clinical Trials Index, which is sponsored by LifeSci Index Partners, LLC.
BBP will track the BioShares Biotechnology Products Index, which is also sponsored by LifeSci Index Partners. That index follows U.S.-listed biotech companies with a primary product offering or product candidate that has landed FDA approval, according to the SEC filing. At the end of the second quarter, the index was home to 43 companies.